- Viral RNA: Compatible with plasma, serum, urine, cell culture media, blood, saliva, cellular suspensions, biopsies, swabs, feces, samples in DNA/RNA Shield, etc.
- Streamlined Workflow: Sample inactivation and easy one-step lysis enables fast processing.
High Sensitivity: Optimized for low viral copy detection for Next-Gen
Sequencing and RT-qPCR.
The Quick-RNA Viral Kit is a quick viral RNA purification kit for viral RNA from plasma, serum, cell culture media, cellular suspensions, urine, blood, saliva and any other biological samples stored in DNA/RNA Shield™.
DNA/RNA Shield™ ensures nucleic acid stability during sample storage/transport at ambient temperatures (4-25°C). The reagent effectively lyses cells and inactivates nucleases and infectious agents (virus).
The kit also features a specialized buffer system that facilitates complete viral
particle lysis for efficient RNA isolation from samples containing enteroviruses,
rhinoviruses, coronaviruses, HIV, HCV, influenza A virus, flaviviruses, measles virus, parainfluenza virus, parvovirus (a ssDNA virus), etc. Viral RNA is bound to the column, washed and eluted.
The isolated high-quality viral RNA is ready for all downstream applications such as Next-Gen Sequencing, hybridization-based and RT/PCR detection.
|RNA is ready for Next-Gen sequencing, RT-qPCR, microarray, hybridization, etc.
|Plasma, serum, saliva, urine, blood, cell culture media, cellular suspensions, biopsies, and swab and fecal samples stored in DNA/RNA Shield
|50 nt to ~200 kb
|10 µg RNA (binding capacity), ≥6 µl (elution volume)
“The Quick-RNA Viral RNA kit performed much better than the RNeasy 96 kit for extracting RNA from dilute samples of virus supernatant. The kit is designed for small-volume elution to automatically concentrate the sample, and it’s designed for viral supernatants rather than cell lysates, so we didn’t need to deal with optimizing added carrier RNA. So in all, it was simpler, easier, and gave us a 10-fold improvement in our limit of detection.”
– S.B., Boehringer Ingelheim, Canada
Quick-RNA Viral Kit
R1034 / R1035
|Quick-RNA Viral Kit
|Quick-RNA Viral Kit
Frequently Asked Questions
Are your products FDA-cleared?
Zymo Research’s products are considered for research use only.
Because the virus (SARS-CoV-2) causing COVID-19 is new, there are no FDA-cleared or approved tests to diagnose or detect it. However, during public health emergencies the FDA is able to issue Emergency Use Authorizations (EUAs) which allows test manufacturers to distribute potentially life-saving technologies prior to clearance or approval after the performance characteristics have already been validated. You can find more information at www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization
Zymo Research is actively working with the FDA to have an EUA approved for a SARS-CoV-2 detection test with its corresponding workflow. This workflow includes DNA/RNA Shield Collection Devices, Quick-DNA/RNA Viral MagBead Kit (R2140), and the Quick-SARS-CoV-2 rRT-PCR Test Kit.
Health organizations have validated Zymo Research’s sample collection and viral extraction kits in their workflows for clinical specimen collection and processing. For the adoption of Zymo products into EUA workflows, further validation on the product’s performance are required. Feel free to contact us, for additional information or assistance: email@example.com.
What viral extraction kits do you recommend?
What automatable options do you provide for viral extraction?
Can you support our COVID-19 testing lab or project?
Yes. We have a dedicated team of specialists readily available to assist you with questions regarding product availability, product recommendations and regulatory requirements. Please email firstname.lastname@example.org.